Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
Lai-Hung Wong, Grace
Wai-Sun Wong, Vincent
Adithya Lesmana, Cosmas Rinaldi
Ong-Go, Arlinking K
Hoon Ahn, Sang
Lik-Yuen Chan, Henry
MetadataShow full item record
Imagenes y Videos
he COVID-19 pandemic has spread rapidly worldwide. It is common to encounter patients with COVID-19 with abnormal liver function, either in the form of hepatitis, cholestasis, or both. The clinical implications of liver derangement might be variable in different clinical scenarios. With growing evidence of its clinical significance, it would be clinically helpful to provide practice recommendations for various common clinical scenarios of liver derangement during the COVID-19 pandemic. The Asia-Pacific Working Group for Liver Derangement during the COVID-19 Pandemic was formed to systematically review the literature with special focus on the clinical management of patients who have been or who are at risk of developing liver derangement during this pandemic. Clinical scenarios covering the use of pharmacological treatment for COVID-19 in the case of liver derangement, and assessment and management of patients with chronic hepatitis B or hepatitis C, non-alcoholic fatty liver disease, liver cirrhosis, and liver transplantation during the pandemic are discussed.
Link to resourcehttps://doi.org/10.1016/
Estadísticas Google Analytics
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.